| (Values in U.S. Thousands) | Sep, 2025 | Jun, 2025 | Mar, 2025 | Dec, 2024 | Sep, 2024 |
| Sales | 7,490 | 8,220 | 8,840 | 12,410 | 13,510 |
| Sales Growth | -8.88% | -7.01% | -28.77% | -8.14% | -6.63% |
| Net Income | 16,900 | 66,930 | -64,700 | 29,210 | 5,610 |
| Net Income Growth | -74.75% | +203.45% | -321.50% | +420.68% | +56,000.01% |
Semler Scientific (SMLR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Semler Scientific, Inc. is a medical risk-assessment company. The Company engages in developing, manufacturing, and marketing patented products that identify the risk profile of medical patients to allow healthcare providers to capture full reimbursement potential for their services. Its products include FloChec (R) which is used in the office setting to allow healthcare providers to measure arterial blood flow in the extremities and is a useful tool for internists and primary care physicians. Semler Scientific, Inc. is headquartered in Portland, Oregon.
Fiscal Year End Date: 12/31